Back to
DAVENPORT & Co LLC
CGTX5 quarters
Position history for
DAVENPORT & Co LLC's holdings in COGNITION THERAPEUTICS INC
Yes. Davenport holds 4,248,410 shares of CGTX (Cognition Therapeutics), worth $4.1M, as of its Q3 2026 13F filing. It reduced the position by 11,101 shares (-0.3%) from Q2 2026. Davenport has held CGTX since Q3 2025, across 5 quarterly 13F filings.
Current Value
$4.1M
Current Shares
4.2M
Total Value Change
+$447,870
Total Shares Change
+1.6M
Quarter-by-Quarter History
Other major holders of CGTX: VANGUARD GROUP INC, Pathstone Holdings, LLC, VANGUARD CAPITAL MANAGEMENT LLC